129 related articles for article (PubMed ID: 32292082)
1. Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold?
Fazio D; Criscuolo E; Piccoli A; Barboni B; Fezza F; Maccarrone M
Expert Opin Drug Discov; 2020 Jul; 15(7):765-778. PubMed ID: 32292082
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).
Lodola A; Castelli R; Mor M; Rivara S
Expert Opin Ther Pat; 2015; 25(11):1247-66. PubMed ID: 26413912
[TBL] [Abstract][Full Text] [Related]
3. Latest advances in the discovery of fatty acid amide hydrolase inhibitors.
Bisogno T; Maccarrone M
Expert Opin Drug Discov; 2013 May; 8(5):509-22. PubMed ID: 23488865
[TBL] [Abstract][Full Text] [Related]
4. Role for fatty acid amide hydrolase (FAAH) in the leptin-mediated effects on feeding and energy balance.
Balsevich G; Sticht M; Bowles NP; Singh A; Lee TTY; Li Z; Chelikani PK; Lee FS; Borgland SL; Hillard CJ; McEwen BS; Hill MN
Proc Natl Acad Sci U S A; 2018 Jul; 115(29):7605-7610. PubMed ID: 29967158
[TBL] [Abstract][Full Text] [Related]
5. Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Pryce G; Cabranes A; Fernández-Ruiz J; Bisogno T; Di Marzo V; Long JZ; Cravatt BF; Giovannoni G; Baker D
Mult Scler; 2013 Dec; 19(14):1896-904. PubMed ID: 23625705
[TBL] [Abstract][Full Text] [Related]
6. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
Pertwee RG
Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
Fowler CJ; Jonsson KO; Tiger G
Biochem Pharmacol; 2001 Sep; 62(5):517-26. PubMed ID: 11585048
[TBL] [Abstract][Full Text] [Related]
8. The interaction of fatty acid amide hydrolase (FAAH) inhibitors with an anandamide carrier protein using (19)F-NMR.
Zhuang J; Yang DP; Nikas SP; Zhao J; Guo J; Makriyannis A
AAPS J; 2013 Apr; 15(2):477-82. PubMed ID: 23344792
[TBL] [Abstract][Full Text] [Related]
9. Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.
Panlilio LV; Thorndike EB; Nikas SP; Alapafuja SO; Bandiera T; Cravatt BF; Makriyannis A; Piomelli D; Goldberg SR; Justinova Z
Psychopharmacology (Berl); 2016 May; 233(10):1879-88. PubMed ID: 26558620
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of diuresis and natriuresis by renomedullary infusion of a dual inhibitor of fatty acid amide hydrolase and monoacylglycerol lipase.
Ahmad A; Daneva Z; Li G; Dempsey SK; Li N; Poklis JL; Lichtman A; Li PL; Ritter JK
Am J Physiol Renal Physiol; 2017 Nov; 313(5):F1068-F1076. PubMed ID: 28768662
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid amide hydrolase inhibitors--progress and potential.
Khanna IK; Alexander CW
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
Cravatt BF; Lichtman AH
Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
[TBL] [Abstract][Full Text] [Related]
14. Computational insights into function and inhibition of fatty acid amide hydrolase.
Palermo G; Rothlisberger U; Cavalli A; De Vivo M
Eur J Med Chem; 2015 Feb; 91():15-26. PubMed ID: 25240419
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor.
Watabiki T; Tsuji N; Kiso T; Ozawa T; Narazaki F; Kakimoto S
Eur J Pharmacol; 2017 Nov; 815():42-48. PubMed ID: 29017758
[TBL] [Abstract][Full Text] [Related]
16. FAAH and anandamide: is 2-AG really the odd one out?
Di Marzo V; Maccarrone M
Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety.
Morena M; Aukema RJ; Leitl KD; Rashid AJ; Vecchiarelli HA; Josselyn SA; Hill MN
J Neurosci; 2019 Feb; 39(7):1275-1292. PubMed ID: 30573646
[TBL] [Abstract][Full Text] [Related]
18. Assay of FAAH Activity.
Bari M; Feole M; Maccarrone M
Methods Mol Biol; 2016; 1412():131-6. PubMed ID: 27245899
[TBL] [Abstract][Full Text] [Related]
19. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
Minkkilä A; Saario S; Nevalainen T
Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
